Prefrontal intermittent theta burst stimulation for thinking problems after ICU delirium
Official title: Prefrontal Theta Burst Stimulation to Improve Cognitive Impairment After ICU Delirium: A Randomized Sham-Controlled Pilot Trial
Run by University of Florida · NCT07452939 · Data updated 2026-11-12
This trial will test whether intermittent theta burst brain stimulation can safely improve thinking, memory, and attention in older adults who had delirium during an ICU stay.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | February 13, 2026 |
| Main results expected | March 21, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07452939 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking, community-dwelling adults age 50–75 who are about three months post-ICU discharge, had documented ICU delirium, can provide a family collateral, and have a MoCA score between 18 and 25.
✕Probably not a fit
People with pre-existing dementia or mild cognitive impairment before their ICU stay, a seizure disorder, major neurological disease, large focal brain lesions, or who cannot travel to the site are unlikely to benefit from or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial enrolls community-dwelling adults aged 50–75 who are about three months after an ICU stay complicated by documented delirium and who have mild cognitive impairment on the MoCA (18–25). Participants receive either active intermittent theta burst stimulation (iTBS), a patterned form of transcranial magnetic stimulation, or a sham procedure applied over the prefrontal cortex across multiple sessions. The study tracks safety, feasibility, and changes in cognitive domains including attention, processing speed, memory, and executive function before and after the intervention. Results will guide whether larger trials of iTBS for post-delirium cognitive impairment are warranted.
Why it matters
Potential benefit: If successful, iTBS could provide a noninvasive option to improve daily thinking, attention, and memory in ICU survivors with lingering cognitive problems.
How similar studies have gone: TMS and iTBS have shown benefit for depression and some cognitive symptoms in other populations, but their use specifically for post-ICU delirium cognitive impairment is novel with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible individuals must have experienced an ICU admission with documented delirium (confirmed via documented Confusion Assessment Method for the ICU score12 \[CAM-ICU\] or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition13(p5) \[DSM-5\] criteria) * Age 50 to 75 years old * 3 months post-ICU discharge at time of enrollment (defined as within 90 ± 14 days) * English fluency * Family or close friend for collateral * Community-dwelling status * Montreal Cognitive Assessment14 score between 18 and 25. Exclusion Criteria: * Diagnosis of mild cognitive impairment or dementia (prior to delirium episode) * Seizure disorder * Other significant neurologic disease (e.g., Parkinson's, Huntington's, Normal pressure hydrocephalus, tumor, progressive supranuclear palsy, multiple sclerosis, hematomas, traumatic or anoxic brain injury) * Structural CT/MRI with evidence of infection or other clinically significant focal lesions (cortical strokes not large enough to distort anatomy and/or multiple lacunar infarctions ≤ 1.5cm and/or extensive white matter disease are allowed) * Unstable or decompensated cardiac disease (e.g., \<3 months myocardial infarction, unstable angina, decompensated congestive heart failure NYHA class 3-4) * Pacemaker * Cochlear implants * Implanted medication pumps * Intracranial metal implants * Previous TMS treatment * Pregnancy (negative urine or serum b-HCG or history of prior surgical sterilization or post-menopausal status \[12 months or more of amenorrhea\]) * Current depressive disorder (Beck Depression Inventory score15 \<13) * History of suicide attempts * Schizophrenia * Bipolar disorder * Alcohol or substance abuse * Severe visual/hearing impairment. * Informant Questionnaire on Cognitive Decline in the Elderly16 (IQCODE) score ≥3.4 (suggesting prior cognitive decline)
Where it's running
-
University of Florida Shands Hospital
Gainesville, Florida, United States Recruiting
Study contacts
- Study coordinator: Shixie Jiang, MD
- Email: delirium-lab@ufl.edu
- Phone: 352-273-5391
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
Just-in-Time Coping Prompts for College Students
We’re testing whether sending brief coping tips at moments of emotional shift can influence how college students react online, drink, or eat when feelings spike.
-
Momentary Coping Prompts and Hair Steroids in College Students
This trial tests whether sending brief coping prompts at moments of emotional volatility helps college students respond to emotions, while collecting hair samples to see if long-term stress hormones relate to those responses.
-
VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne
This Phase 2 study tests VM100, a nutritional drink, in boys aged 8 and up with Duchenne muscular dystrophy to see if it can improve quality of life and reduce fatigue.
-
Muscle health before and after lung transplant in adults
This study tests how respiratory and leg muscle health relates to physical function and recovery in adults awaiting and after lung transplantation.
-
Acute intermittent hypercapnia-based interventions for upper airway and axial control in Parkinsonism
This randomized pilot study tests whether a single session of acute intermittent hypercapnic hypoxia or hypercapnic normoxia can improve upper airway and axial motor function in adults with Parkinsonism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.